thiosulfates has been researched along with Minimal Disease, Residual in 2 studies
Thiosulfates: Inorganic salts of thiosulfuric acid possessing the general formula R2S2O3.
thiosulfate(2-) : A divalent inorganic anion obtained by removal of both protons from thiosulfuric acid.
| Excerpt | Relevance | Reference |
|---|---|---|
| "As in many ovarian cancer patients the disease remains confined to the peritoneal cavity, intraperitoneal (i." | 2.68 | Experience with intraperitoneal cisplatin and etoposide and i.v. sodium thiosulphate protection in ovarian cancer patients with either pathologically complete response or minimal residual disease. ( Burger, CW; Hoekman, K; van Rijswijk, RE; Verheijen, RH; Vermorken, JB, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Jong, RS | 1 |
| Willemse, PH | 1 |
| Boonstra, H | 1 |
| de Vries, EG | 1 |
| van der Graaf, WT | 1 |
| Sleijfer, DT | 1 |
| van der Zee, AG | 1 |
| Mulder, NH | 1 |
| van Rijswijk, RE | 1 |
| Hoekman, K | 1 |
| Burger, CW | 1 |
| Verheijen, RH | 1 |
| Vermorken, JB | 1 |
2 trials available for thiosulfates and Minimal Disease, Residual
| Article | Year |
|---|---|
Phase II study of intraperitoneal cisplatin plus systemic etoposide as second-line treatment in patients with small volume residual ovarian cancer.
Topics: Administration, Topical; Adult; Aged; Antioxidants; Cisplatin; Disease-Free Survival; Drug Therapy, | 1995 |
Experience with intraperitoneal cisplatin and etoposide and i.v. sodium thiosulphate protection in ovarian cancer patients with either pathologically complete response or minimal residual disease.
Topics: Adult; Aged; Antidotes; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Prot | 1997 |